Evidence supporting the use of therapeutic drug monitoring of ganciclovir in transplantation
DD Wong, SA Ho, A Domazetovska… - Current Opinion in …, 2023 - journals.lww.com
Evidence supporting the use of therapeutic drug monitoring o... : Current Opinion in Infectious
Diseases Evidence supporting the use of therapeutic drug monitoring of ganciclovir in …
Diseases Evidence supporting the use of therapeutic drug monitoring of ganciclovir in …
[HTML][HTML] Infection-related mortality in adults and children undergoing allogeneic hematopoietic cell transplantation: an Australian registry report
J Lindsay, I Kerridge, L Wilcox, S Tran… - … and Cellular Therapy, 2021 - Elsevier
Infection-related mortality (IRM) is the most common non-relapse-related cause of death
reported after allogeneic hematopoietic cell transplantation (HCT). Information on the …
reported after allogeneic hematopoietic cell transplantation (HCT). Information on the …
Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre‐transplant predictors of survival, reactivation, and spontaneous clearance
Background Cytomegalovirus (CMV) reactivation is a frequent complication after allogeneic
hematopoietic cell transplant (alloHCT). Method We analyzed 159 alloHCT recipients with …
hematopoietic cell transplant (alloHCT). Method We analyzed 159 alloHCT recipients with …
In-depth summary over cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation recipients
S Karami, E Roshandel, H Ghaffari Nazari, A Hajifathali… - Virusdisease, 2021 - Springer
In this study, we reviewed various aspects of cytomegalovirus infection, including
pathophysiology, diagnosis methods, and antiviral treatments. Background: Infections …
pathophysiology, diagnosis methods, and antiviral treatments. Background: Infections …
[HTML][HTML] Current research status of cytomegalovirus infection after hematopoietic stem cell transplantation: a bibliometric analysis
P Chen, Z Du, S Qiu, H Wang… - Annals of Palliative …, 2021 - apm.amegroups.org
Background: Hematopoietic stem cell transplantation (HSCT) is an effective method for the
treatment of hematological malignancies, severe aplastic anemia, and myelodysplastic …
treatment of hematological malignancies, severe aplastic anemia, and myelodysplastic …
High Monocyte Count Associated with Human Cytomegalovirus Replication In Vivo and Glucocorticoid Therapy May Be a Hallmark of Disease
P Zdziarski, A Gamian - International Journal of Molecular Sciences, 2022 - mdpi.com
Cytomegalovirus (CMV) syndrome and infectious disease are defined as pathogen
detection with appropriate clinical symptoms, but there are not pathognomonic signs of CMV …
detection with appropriate clinical symptoms, but there are not pathognomonic signs of CMV …
Development of a highly cytotoxic, clinical-grade virus-specific T cell product for adoptive T cell therapy
FA Rocha, CRF Silveira, AF Dos Santos… - Cellular …, 2024 - Elsevier
At present, recipients of allogeneic hematopoietic stem-cells are still suffering from recurrent
infections after transplantation. Infusion of virus-specific T cells (VST) post-transplant …
infections after transplantation. Infusion of virus-specific T cells (VST) post-transplant …
Clinical characteristics and viral load patterns in children with cytomegalovirus gastrointestinal disease after allogeneic hematopoietic stem cell transplantation
HM Kang, SK Kim, IH Ryu, JW Lee, DG Lee… - Bone Marrow …, 2021 - nature.com
Cytomegalovirus (CMV) reactivation in allogeneic hematopoietic stem cell transplantation
(allo-HSCT) causes significant morbidity and mortality. This study aimed to investigate the …
(allo-HSCT) causes significant morbidity and mortality. This study aimed to investigate the …
Risk factors for CMV infection within 100 days posttransplantation in patients with acute leukemia
J Chen, A Pang, Y Zhao, L Liu, R Ma, J Wei, X Chen… - Blood Science, 2022 - mednexus.org
Objective: To investigate the risk factors for cytomegalovirus (CMV) infection within 100 days
and the relationship between early CMV infection and 1-year relapse for patients with acute …
and the relationship between early CMV infection and 1-year relapse for patients with acute …
[HTML][HTML] Gaining Consensus Around Patient Risk Groups and Prognostic Profiles to Guide CMV Management Among Patients With Allogeneic Hematopoietic Stem …
M Graf, R Tuly, P Pednekar, C Wang, K Batt - Transplantation Proceedings, 2024 - Elsevier
Introduction This study aimed to characterize patient risk groups and prognostic profiles to
optimize clinical decision-making and guide appropriate medical cytomegalovirus (CMV) …
optimize clinical decision-making and guide appropriate medical cytomegalovirus (CMV) …